前收市價 | 2,012.00 |
開市 | 2,018.00 |
買盤 | 2,011.00 x 無 |
賣出價 | 2,003.00 x 無 |
今日波幅 | 2,000.00 - 2,030.00 |
52 週波幅 | 1,825.00 - 2,939.00 |
成交量 | |
平均成交量 | 126,437 |
市值 | 129.376B |
Beta 值 (5 年,每月) | 0.79 |
市盈率 (最近 12 個月) | 24.16 |
每股盈利 (最近 12 個月) | 82.92 |
業績公佈日 | 2024年8月01日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 2,669.48 |
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to […]
Genmab stock slumped Wednesday after the Danish biotech announced it will buy privately held ProfoundBio for $1.8 billion.
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]